Drugmakers 'Jazzed,' but More to Come
Breath of a Salesman: Off-Label Case Won on Free-Speech Basis
By Randy Osborne
Wednesday, December 5, 2012
In a decision hailed by some as a free-speech victory and by others as a ruling that gives drugmakers free rein to promote their goods off-label, federal appeals judges threw out the conviction of a former sales representative with Orphan Medical Inc. (acquired by Jazz Pharmaceuticals plc), who claimed his First Amendment rights were violated.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.